Neoadjuvant Immunotherapy Shows Promise for High-Risk HCC ...Middle East

News by : (Medscape) -
Neoadjuvant immunotherapy yielded similar survival and surgical outcomes to upfront surgery in high-risk HCC and could broaden surgical options for traditionally unresectable cases. Medscape Medical News

Hence then, the article about neoadjuvant immunotherapy shows promise for high risk hcc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Neoadjuvant Immunotherapy Shows Promise for High-Risk HCC )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار